SIMOS SIMEONIDIS, PHD JOINS ALLY BRIDGE GROUP AS CO-CEO AND CO-CIO
NEW YORK, July 21, 2022 /PRNewswire/ --Ally Bridge Group (the "Firm") is pleased to announce Simos Simeonidis, PhD joined the Firm as Co-Chief Executive Officer and Co-Chief Investment Officer based in New York. Dr. Simeonidis is also assuming the role of Portfolio Manager for Ally Bridge Group's public equity strategy. Ally Bridge Group is a global healthcare investment manager focused on high-impact life science innovation addressing unmet medical needs. The Firm manages both private equity vehicles and a long-biased public equity strategy with specialization across the medical...
Source: singaporestar.com